Mass screening and health controls
Nordisk Medicin 95(4): 113-115
1980
ISSN/ISBN: 0029-1420 PMID: 7367245 Document Number: 157881
Document emailed within 1 workday
Related Documents
Kayima, J.K. 1997: Utility of mass screening programmes in health East African Medical Journal 74(8): 465-466Hornei, R.; Thiele, E.; Hollenbach, K. 1988: Mass screening for the evaluation of individual and community health Zeitschrift für Arztliche Fortbildung 82(19): 948-950
Sawada, T.; Shikata, T.; Matsumura, T.; Kawakatsu, H.; Sugimoto, T. 1994: Analysis of 598 cases of neuroblastoma (NB) detected by screening and changes in the age distribution and incidence of NB patients after mass screening in infants in Japan. NB Screening Study Group Progress in Clinical and Biological Research 385: 371-375
Miyake, K. 1986: Present status and problems of mass screening--from the viewpoint of public health Hokkaido Journal of Medical Science 61(4): 515-519
Osin, A.I. 1988: A method of analyzing the effectiveness of mass screening of children based on health status indicators Sovetskoe Zdravookhranenie 10: 30-33
Altarac, S. 2013: Individualized "opportunistic" screening for prostate cancer instead of mass population screening Lijecnicki Vjesnik 135(1-2): 51-52
Komeda, Y.; Suzuki, R.; Maeda, Y.; Okabe, S.; Kawamura, J.; Hioki, T.; Ohawa, M. 1994: Mass screening for prostate cancer at a local town--five-year results and screening system Hinyokika Kiyo. Acta Urologica Japonica 40(4): 315-318
Trehu, E.G.; Cooper, J.N. 1992: Cost of screening for colorectal cancer: results of a community mass screening program and review of the literature Southern Medical Journal 85(3): 248-254
Tonks, A. 1993: Ethics committee demands controls on genetic screening Bmj 307(6918): 1513
Durand-Zaleski, I.; Bastuji-Garin, S. 2000: Evaluation of diagnostic or screening procedures. Validity of tests, sensitivity, specificity, predictive values. Definition and indications for mass screening La Revue du Praticien 50(10): 1155-1158
Mathias, D.; Gebhard, J.; Wilhelm, L.; Schmidt, H.-Gayk; Mathias, I. 2008: 26 Years of External Quality Controls for the Screening of Congenital Metabolic Disorders in Newborns – a Summary of the Results Clinical Laboratory 54(3-4): 103-108
Du, Y.; Li, Q.; Wu, C.; Zhang, Y. 2015: Rapid screening and quantitative detection of 11 illegally added antidiabetics in health care products by ultra performance liquid chromatography-quadrupole/electrostatic field orbitrap high resolution mass spectrometry Se Pu 33(4): 371-376
Akamatsu, N.; Ide, M.; Ueda, Y.; Kondo, Y.; Nakamura, S.; Mori, T.; Ogimoto, I.; Yoshimura, T. 1986: A population survey on mass screening program for gastric cancer part 1. population characteristics related to examination rates for screening program Journal of UOEH 8(2): 177-184
Olofsson, C. 1979: Who controls health care? 5. the future Vardfacket 3(10): 66-68
Fujimoto, I. 1984: Mass screening program for cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 11(3 Pt 2): 727-732
Cottu, P.-H.; Cuvier, C.; Perret, F.; Gorins, A.é; Espié, M. 2003: Mass screening for breast cancer Presse Medicale 32(3): 120-124
Furuya, S. 1986: Mass screening of prostatic diseases Hokkaido Journal of Medical Science 61(4): 520
Timonen, S. 1971: Gynaecological mass screening in Finland Minerva Ginecologica 23(1): 7-11
Ito, K.; Yamamoto, T.; Kubota, Y.; Yamanaka, H. 2000: Mass screening for prostate cancer Nihon Rinsho. Japanese Journal of Clinical Medicine 58 Suppl: 365-368
Grabowski, M.; Golański, J. 1981: Role of mass screening in medicine Wiadomosci Lekarskie 34(10): 867-870